LifestyleExercise

Exercise reduces the risk of hepatic steatosis, fibrosis, and hepatocellular carcinoma in a dose-dependent manner in individuals with MASLD.

The paper reports that exercise is associated with a dose-dependent reduction in the risk of hepatic steatosis, fibrosis, and hepatocellular carcinoma in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). This effect is partly independent of weight loss, and lifestyle interventions including exercise improve cardiometabolic health beyond the liver.

Last updated: Jul 28, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score34/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Non-pharmacological treatment of MASLD.

observational

Dufour JF, Berzigotti A · Diabetologia (2026)

Participants: N/A
Duration: N/A
Intervention: Exercise (dose-dependent, combined with energy restriction for weight loss)
Outcome: Risk of hepatic steatosis, fibrosis, and hepatocellular carcinoma
Effect Size: N/A (dose-dependent association reported, no specific effect size given)
Population: Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD), with or without obesity

Result:

PubMed: 42502137DOI: 10.1007/s00125-026-06811-5

Mechanism Graph

Exercise reduces hepatic fat accumulation
↓
Improves insulin sensitivity and metabolic function
↓
Decreases inflammation and fibrosis progression
↓
Result: Reduced risk of steatosis, fibrosis, and hepatocellular carcinoma

Limitations

  • ⚠Adherence to lifestyle interventions is suboptimal, especially long-term
  • ⚠Variability in individual response to exercise requires further research on biomarkers for personalized approaches

Frequently Asked Questions

What type of exercise is recommended for MASLD?▼

The abstract does not specify exercise type, but it emphasizes dose-dependent benefits and combining exercise with energy restriction for weight loss.

Is weight loss necessary for exercise to benefit MASLD?▼

No, the effects of exercise are partly independent of weight reduction, though weight loss remains the cornerstone of non-pharmacological strategies.

How much exercise is needed to reduce liver cancer risk in MASLD?▼

The abstract states a dose-dependent reduction in risk but does not provide specific exercise amounts or durations.

Can exercise alone reverse liver fibrosis in MASLD?▼

The abstract suggests exercise reduces the risk of fibrosis, but does not claim reversal; it is part of a broader lifestyle intervention.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Dufour JF, Berzigotti A. "Non-pharmacological treatment of MASLD.." Diabetologia, 2026. PMID: 42502137 DOI: 10.1007/s00125-026-06811-5
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.